IMMUNO-COV™ – The Test for Antibodies that Block SARS-CoV-2 Infection Read More

Publications

Naik et al.

Comparative Oncology Evaluation of Intravenous Recombinant Oncolytic Vesicular Stomatitis Virus Therapy in Spontaneous Canine Cancer

Mol Cancer Ther. 2018 Jan;17(1):316-326. doi: 10.1158/1535-7163.MCT-17-0432. Epub 2017 Nov 20.

Lauro Velazquez-Salinas et al.

Recombinant Vesicular Stomatitis Virus (VSV) Is Nonpathogenic and Nontransmissible in Pigs, a Natural Host of VSV

Hum Gene Ther Clin Dev. 2017 Jun 1; 28(2): 108–115.

Zhang et al.

Robust Oncolytic Virotherapy Induces Tumor Lysis Syndrome and Associated Toxicities in the MPC-11 Plasmacytoma Model

Mol Ther. 2016 Dec; 24(12): 2109–2117.

LeBlanc et al.

Safety studies on intravenous administration of oncolytic recombinant vesicular stomatitis virus in purpose-bred beagle dogs.

Hum Gene Ther Clin Dev. 2013 Dec;24(4):174-81. doi: 10.1089/humc.2013.165.

Naik et al.

Curative one-shot systemic virotherapy in murine myeloma

Leukemia. 2012 Aug;26(8):1870-8. doi: 10.1038/leu.2012.70. Epub 2012 Mar 19.